Exabis Library
Welcome to the e-CCO Library!
P035: Lamina propria CD4+LAP+ Foxp3- regulatory cells are involved in limiting the disease extension in Ulcerative Colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P035: Pharmacological inhibition of the canonical WNT signalling pathway represents a potential novel therapy for fibrosis in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P035: Potential biomarkers for diagnosis through proteomics, in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P035: Serum markers predict outcome to ustekinumab in patients with refractory Crohn’s disease and provide insides in the mechanism of action
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P035: TNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P036 A novel p53-mediated mouse model of inflammatory bowel disease-associated colorectal cancer
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0360: Bowel Ultrasonography and Computed Tomography tell the same story using different languages in analizing Crohnˈs disease lesions
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0361: Clinical outcomes of acute severe colitis in Latin American: a case series.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0362: Bowel urgency in inflammatory bowel disease: The URGENT index
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0363: Explore the application value of serum GOLM1 in the diagnosis of Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0364: Establishment and validation of a central reader pool for magnetic resonance enterography (MRE) for use in Crohn’s disease clinical trials
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0365: The evolution of Geldof fistula class in patients with Crohn's disease perianal fistula
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0366: Endoscopic remission in Crohn’s diseasex7x7x7 the CREDO trial: Inter-reader variation study of the detection of endoscopic lesions assumed consensually to be related to remission.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0367: A Clustering approach to discriminate slow and rapid biologics switchers in difficult-to-treat Crohn’s Disease patients.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0368: Novel endoluminal parameters to predict primary loss of response in patients with Crohn’s disease: a national survey and multi-centre study.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0369: The use of exhaled volatile organic compounds for the non-invasive assessment of endoscopic inflammation in patients with ileal pouch anal anastomosis (IPAA)
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P036: Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P036: Colon targeted delivery of tofacitinib inhibits oxazolone-induced colitis in mice, despite low systemic exposure
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P036: Expression of CD69 on peripheral lymphocytes predicts treatment response in Acute Severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P036: Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM